NF-κB activation in IECs can result in the increase of inflammatory cytokines, which are important in the pathogenesis of IBD (Egan et al., 2004; Mikuda et al., 2020; Rizzo et al., 2021). Here, NFKB1 is linked to inflammatory bowel disease.